Ionis Pharmaceuticals, Inc.
IONS
$81.84
$0.530.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -128.61M | 123.55M | -146.94M | -104.35M | -140.48M |
| Total Depreciation and Amortization | 4.50M | 5.45M | 5.40M | 5.27M | 5.49M |
| Total Amortization of Deferred Charges | 1.65M | 1.65M | 1.64M | 1.67M | 1.68M |
| Total Other Non-Cash Items | -3.57M | 49.17M | 30.30M | 42.65M | 26.78M |
| Change in Net Operating Assets | -5.41M | -28.48M | -41.18M | -61.39M | -8.46M |
| Cash from Operations | -131.44M | 151.34M | -150.78M | -116.14M | -114.99M |
| Capital Expenditure | -5.27M | -12.31M | -12.58M | -25.50M | -9.06M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.61M | -107.76M | 183.04M | 93.71M | -331.74M |
| Cash from Investing | 91.34M | -120.07M | 170.46M | 68.21M | -340.80M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -41.00K | -40.00K | -42.00K | -44.55M | -48.00K |
| Issuance of Common Stock | 81.26M | 1.29M | 2.24M | 429.00K | 496.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 81.22M | 1.25M | 2.20M | -44.12M | 496.05M |
| Foreign Exchange rate Adjustments | -82.00K | 595.00K | 232.00K | -486.00K | 350.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.04M | 33.11M | 22.12M | -92.53M | 40.61M |